Resistance or pitfall in heparin monitoring: An ongoing issue in COVID-19 anticoagulation

Mochamad Yusuf Alsagaff, Eka Prasetya Budi Mulia

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)e135-e137
JournalInternational Journal of Laboratory Hematology
Volume44
Issue number4
DOIs
Publication statusPublished - Aug 2022

Keywords

  • COVID-19
  • activated partial thromboplastin time
  • anti-Xa
  • heparin
  • intensive care
  • resistance

Cite this